Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Wenjun Wang, Ying Xu, Chang Jiang & Yanhang Gao. (2019) Advances in the treatment of severe alcoholic hepatitis. Current Medical Research and Opinion 35:2, pages 261-273.
Read now
Read now
Banumathi K. Cole, Ryan E. Feaver, Brian R. Wamhoff & Ajit Dash. (2018) Non-alcoholic fatty liver disease (NAFLD) models in drug discovery. Expert Opinion on Drug Discovery 13:2, pages 193-205.
Read now
Read now
Richard J. Weaver, Catherine Betts, Eric A.G. Blomme, Helga H.J. Gerets, Klaus Gjervig Jensen, Philip G. Hewitt, Satu Juhila, Gilles Labbe, Michael J. Liguori, Natalie Mesens, Monday O. Ogese, Mikael Persson, Jan Snoeys, James L. Stevens, Tracy Walker & B. Kevin Park. (2017) Test systems in drug discovery for hazard identification and risk assessment of human drug-induced liver injury. Expert Opinion on Drug Metabolism & Toxicology 13:7, pages 767-782.
Read now
Read now
Articles from other publishers (33)
Soheyl Mirzababaei, Mona Navaei-Nigjeh, Mohammad Abdollahi & Amir Shamloo. 2023. Principles of Human Organs-on-Chips. Principles of Human Organs-on-Chips
195
249
.
Parth Malik & Tapan Kumar Mukherjee. 2023. Practical Approach to Mammalian Cell and Organ Culture. Practical Approach to Mammalian Cell and Organ Culture
687
727
.
Parth Malik & Tapan Kumar Mukherjee. 2022. Practical Approach to Mammalian Cell and Organ Culture. Practical Approach to Mammalian Cell and Organ Culture
1
40
.
Chase P. Monckton, Aidan Brougham-Cook, Gregory H. Underhill & Salman R. Khetani. (2022) Modulation of human iPSC-derived hepatocyte phenotype via extracellular matrix microarrays. Acta Biomaterialia 153, pages 216-230.
Crossref
Crossref
Baeckkyoung Sung. (2022) In silico modeling of endocrine organ-on-a-chip systems. Mathematical Biosciences 352, pages 108900.
Crossref
Crossref
Antonio Segovia-Zafra, Daniel E. Di Zeo-Sánchez, Carlos López-Gómez, Zeus Pérez-Valdés, Eduardo García-Fuentes, Raúl J. Andrade, M. Isabel Lucena & Marina Villanueva-Paz. (2021) Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction. Acta Pharmaceutica Sinica B 11:12, pages 3685-3726.
Crossref
Crossref
David A. Kukla & Salman R. Khetani. (2021) Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine. Seminars in Liver Disease 41:03, pages 368-392.
Crossref
Crossref
Manuele Gori, Sara Maria Giannitelli, Andrea Zancla, Pamela Mozetic, Marcella Trombetta, Nicolò Merendino & Alberto Rainer. (2020) Quercetin and hydroxytyrosol as modulators of hepatic steatosis: A NAFLD‐on‐a‐chip study. Biotechnology and Bioengineering 118:1, pages 142-152.
Crossref
Crossref
Paul A. Walker, Stephanie Ryder, Andrea Lavado, Clive Dilworth & Robert J. Riley. (2020) The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development. Archives of Toxicology 94:8, pages 2559-2585.
Crossref
Crossref
David A. Kukla, Alexandra L. Crampton, David K. Wood & Salman R. Khetani. (2020) Microscale Collagen and Fibroblast Interactions Enhance Primary Human Hepatocyte Functions in Three-Dimensional Models. Gene Expression 20:1, pages 1-18.
Crossref
Crossref
Richard J. Weaver, Eric A. Blomme, Amy E. Chadwick, Ian M. Copple, Helga H. J. Gerets, Christopher E. Goldring, Andre Guillouzo, Philip G. Hewitt, Magnus Ingelman-Sundberg, Klaus Gjervig Jensen, Satu Juhila, Ursula Klingmüller, Gilles Labbe, Michael J. Liguori, Cerys A. Lovatt, Paul Morgan, Dean J. Naisbitt, Raymond H. H. Pieters, Jan Snoeys, Bob van de Water, Dominic P. Williams & B. Kevin Park. (2019) Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models. Nature Reviews Drug Discovery 19:2, pages 131-148.
Crossref
Crossref
Jason Wang, Alastair Khodabukus, Lingjun Rao, Keith Vandusen, Nadia Abutaleb & Nenad Bursac. (2019) Engineered skeletal muscles for disease modeling and drug discovery. Biomaterials 221, pages 119416.
Crossref
Crossref
Sebastian Prill, Andrea Caddeo, Guido Baselli, Oveis Jamialahmadi, Paola Dongiovanni, Raffaela Rametta, Kajsa P. Kanebratt, Arturo Pujia, Piero Pingitore, Rosellina Margherita Mancina, Daniel Lindén, Carl Whatling, Annika Janefeldt, Mikael Kozyra, Magnus Ingelman-Sundberg, Luca Valenti, Tommy B. Andersson & Stefano Romeo. (2019) The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids. Scientific Reports 9:1.
Crossref
Crossref
Richard J Weaver & Jean-Pierre Valentin. (2019) Today’s Challenges to De-Risk and Predict Drug Safety in Human “Mind-the-Gap”. Toxicological Sciences 167:2, pages 307-321.
Crossref
Crossref
Julia Rogal, Aline Zbinden, Katja Schenke-Layland & Peter Loskill. (2019) Stem-cell based organ-on-a-chip models for diabetes research. Advanced Drug Delivery Reviews 140, pages 101-128.
Crossref
Crossref
Anne F. Pihl, Anna F. Offersgaard, Christian K. Mathiesen, Jannick Prentoe, Ulrik Fahnøe, Henrik Krarup, Jens Bukh & Judith M. Gottwein. (2018) High density Huh7.5 cell hollow fiber bioreactor culture for high-yield production of hepatitis C virus and studies of antivirals. Scientific Reports 8:1.
Crossref
Crossref
Hugues de Boussac, Claire Gondeau, Philippe Briolotti, Cédric Duret, Fridolin Treindl, Michael Römer, Jean-Michel Fabre, Astrid Herrero, Jeanne Ramos, Patrick Maurel, Markus Templin, Sabine Gerbal-Chaloin & Martine Daujat-Chavanieu. (2018) Epidermal Growth Factor Represses Constitutive Androstane Receptor Expression in Primary Human Hepatocytes and Favors Regulation by Pregnane X Receptor. Drug Metabolism and Disposition 46:3, pages 223-236.
Crossref
Crossref
N. P. Macdonald, A. Menachery, J. Reboud & J. M. Cooper. (2018) Creating tissue on chip constructs in microtitre plates for drug discovery. RSC Advances 8:18, pages 9603-9610.
Crossref
Crossref
Gabriel R. LiguoriBertus F. JeronimusTácia T. de Aquinas LiguoriLuiz Felipe P. MoreiraMartin C. Harmsen. (2017)
Ethical Issues in the Use of Animal Models for Tissue Engineering: Reflections on Legal Aspects, Moral Theory, Three Rs Strategies, and Harm–Benefit Analysis
. Tissue Engineering Part C: Methods 23:12, pages 850-862.
Crossref
Crossref
Aleksander Skardal, Sean V. Murphy, Mahesh Devarasetty, Ivy Mead, Hyun-Wook Kang, Young-Joon Seol, Yu Shrike Zhang, Su-Ryon Shin, Liang Zhao, Julio Aleman, Adam R. Hall, Thomas D. Shupe, Andre Kleensang, Mehmet R. Dokmeci, Sang Jin Lee, John D. Jackson, James J. Yoo, Thomas Hartung, Ali Khademhosseini, Shay Soker, Colin E. Bishop & Anthony Atala. (2017) Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform. Scientific Reports 7:1.
Crossref
Crossref
Rami Mhanna & Anwarul Hasan. 2017. Tissue Engineering for Artificial Organs. Tissue Engineering for Artificial Organs
1
34
.
Brenton R. Ware & Salman R. Khetani. (2017) Engineered Liver Platforms for Different Phases of Drug Development. Trends in Biotechnology 35:2, pages 172-183.
Crossref
Crossref
Fatemeh Aleahmad, Tahereh Talaei-Khozani, Sareh Rajabi-Zeleti, Mahsa Sani, Sasan Jalili-Firoozinezhad, Shahin Bonakdar, Sanaz Heshmat-Azad, Mahnaz Azarnia & Mansoureh Jaberipour. (2017) Fabrication and Characterization of Heparin/Collagen Sponge for in Vitro Differentiation of Wharton’s Jelly-Derived Mesenchymal Stem Cells into Hepatocytes. Hepatitis Monthly 17:2.
Crossref
Crossref
Tomasz Kostrzewski, Terri Cornforth, Sophie A Snow, Larissa Ouro-Gnao, Cliff Rowe, Emma M Large & David J Hughes. (2017) Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease. World Journal of Gastroenterology 23:2, pages 204.
Crossref
Crossref
Boyang Zhang & Milica Radisic. (2017) Organ-on-a-chip devices advance to market. Lab on a Chip 17:14, pages 2395-2420.
Crossref
Crossref
Marisa L. Hovlid & Elizabeth A. Winzeler. (2016) Phenotypic Screens in Antimalarial Drug Discovery. Trends in Parasitology 32:9, pages 697-707.
Crossref
Crossref
Megan J. Neufeld, Brenton R. Ware, Alec Lutzke, Salman R. Khetani & Melissa M. Reynolds. (2016) Water-Stable Metal–Organic Framework/Polymer Composites Compatible with Human Hepatocytes. ACS Applied Materials & Interfaces 8:30, pages 19343-19352.
Crossref
Crossref
Zara Hannoun, Clara Steichen, Noushin Dianat, Anne Weber & Anne Dubart-Kupperschmitt. (2016) The potential of induced pluripotent stem cell derived hepatocytes. Journal of Hepatology 65:1, pages 182-199.
Crossref
Crossref
Matthew D. Davidson, Kimberly R. Ballinger & Salman R. Khetani. (2016) Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes. Scientific Reports 6:1.
Crossref
Crossref
Michaël Maes, Sara Crespo Yanguas, Joost Willebrords & Mathieu Vinken. (2015) Models and methods for in vitro testing of hepatic gap junctional communication. Toxicology in Vitro 30:1, pages 569-577.
Crossref
Crossref
Mathieu Vinken. (2015) Adverse Outcome Pathways and Drug-Induced Liver Injury Testing. Chemical Research in Toxicology 28:7, pages 1391-1397.
Crossref
Crossref
Joost Willebrords, Isabel Veloso Alves Pereira, Michaël Maes, Sara Crespo Yanguas, Isabelle Colle, Bert Van Den Bossche, Tereza Cristina Da Silva, Cláudia Pinto Marques Souza de Oliveira, Wellington Andraus, Venâncio Avancini Alves, Bruno Cogliati & Mathieu Vinken. (2015) Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research. Progress in Lipid Research 59, pages 106-125.
Crossref
Crossref
Da Yoon No, Kwang-Ho Lee, Jaeseo Lee & Sang-Hoon Lee. (2015) 3D liver models on a microplatform: well-defined culture, engineering of liver tissue and liver-on-a-chip. Lab on a Chip 15:19, pages 3822-3837.
Crossref
Crossref